Articles Levetiracetam versus phenytoin for secondline treatment of convulsive status epilepticus in children ConSEPT an openlabel multicentre randomised controlled trial

[Articles] Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial

20:32 EDT 17 Apr 2019 | The Lancet

Levetiracetam is not superior to phenytoin for second-line management of paediatric convulsive status epilepticus.

More From BioPortfolio on "[Articles] Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial"